Combination Of Baclofen, Acamprosate And Medium Chain Triglycerides For The Treatment Of Neurological Disorders

  • Published: Sep 23, 2016
  • Earliest Priority: Feb 11 2014
  • Family: 13
  • Cited Works: 54
  • Cited by: 0
  • Cites: 0
  • Additional Info: Cited Works Published

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.


The present invention relates to combinations and methods for the treatment of neurological disorders related Amyloid beta toxicity and/or neuronal death and/or glucose impaired neuronal metabolism. More specifically, the present invention relates to novel combinatorial therapies of Alzheimer's disease, Alzheimer's disease related disorders, frontotemporal dementia, Parkinson's disease, Lewy body dementia, Huntington's disease, peripheral neuropathies, alcoholism or alcohol withdrawal, neurological manifestations of drug abuse or drug abuse withdrawal, amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injury, epilepsy, traumatic brain injury or brain ischemic events based on baclofen, acamprosate and at least one medium chain triglyceride.


Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Sep 23, 2016
  • Application: Feb 10, 2015
    KR KR 20167025118 A
  • Priority: Feb 10, 2015
    EP EP 2015052694 W
  • Priority: Feb 11, 2014
    US US 201461938340 P

Download Citation

Sign in to the Lens